At a glance
- Originator Chiesi
- Class Neuroprotectants; Nootropics
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 21 May 1998 Discontinued-I for Cognition disorders in Italy (Unknown route)
- 21 Jan 1997 Phase-I clinical trials for Cognition disorders in Italy (Unknown route)